Rhode Island

Overview

Rhode Island legalized medical cannabis via the Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act in 2006 (vetoed by the Governor; veto overridden by the General Assembly), codified at R.I.G.L. Chapter 21-28.6. Adult-use cannabis was legalized via the Rhode Island Cannabis Act, signed by Governor Daniel McKee on May 25, 2022 and codified at R.I.G.L. Chapter 21-28.11. Licensed adult-use retail sales began December 1, 2022.

The Cannabis Control Commission regulates adult-use licensing; the Office of Cannabis Regulation within the Department of Business Regulation (DBR) administers the medical-marijuana program.

Adult-use (Cannabis Act, 2022)

• Public possession: 1 ounce of cannabis flower or 5 grams of concentrate.
• In-residence: up to 10 ounces at home.
• Home cultivation: up to 3 mature plants and 3 seedlings per adult, with a household cap of 6 mature. Plants must be kept secure and out of public view.
• Tax: 10% state cannabis excise tax + 7% state sales tax + 3% local-option tax.
• Past convictions: the Cannabis Act included automatic expungement of certain prior cannabis-possession convictions.

Medical program (Slater Medical Marijuana Act, 2006)

Qualifying conditions

The Rhode Island medical program enumerates qualifying conditions including:

• Cancer, glaucoma, HIV/AIDS, hepatitis C
• ALS, multiple sclerosis, Parkinson's disease, Alzheimer's disease
• Crohn's disease
• Severe chronic pain, severe nausea
• Cachexia / wasting
• Seizure disorders, epilepsy
• Post-traumatic stress disorder
• Autism spectrum disorder
• Terminal illness

Patient access

• Possession: up to 2.5 ounces over any 15-day period under medical registration.
• Home cultivation: registered patients with plant-tags may grow 12 mature plants and 12 seedlings.
• Reciprocity: Rhode Island honors out-of-state medical cards at licensed medical dispensaries.
• Approved forms: flower, edibles, oils, tinctures, capsules, vapes, topicals.

Recreational penalties

Possession of cannabis in excess of adult-use limits is regulated under R.I.G.L. Chapter 21-28 (Uniform Controlled Substances Act). Over-limit possession is generally a misdemeanor for first offenses; unlicensed manufacture or distribution scales to felony.

Patients and caregivers

• Patient minimum age: 18. Minor patients require parent/legal guardian as designated caregiver plus physician certification.
• Caregiver minimum age: 21.
• Caregivers per patient: up to 2 designated caregivers per patient.
• Caregiver registration: via the Office of Cannabis Regulation at DBR; background check.

Patient registration steps

1. Schedule a visit with a Rhode Island-licensed physician, nurse practitioner, or physician assistant willing to certify a qualifying condition through a bona fide patient-provider relationship.
2. The provider submits a written certification through the DBR Office of Cannabis Regulation portal.
3. The patient applies through the OCR portal, submits identity documents, proof of Rhode Island residency, and a current photo. The standard application fee is $50; reduced to $25 for patients receiving Medicaid, SSI, or with hardship documentation.
4. Approved patients receive a Medical Marijuana Program ID Card valid for one year and renewable. The card authorizes purchases at any licensed Rhode Island compassion center under medical-program pricing and the expanded patient home-cultivation rights (with plant-tag registration).

Minor patients require a parent or legal guardian as designated caregiver and a second physician's concurring certification. The caregiver completes a separate application and Rhode Island Attorney General background check.

Reciprocity and visiting patients

Rhode Island's framework is dual-track for visitors:

• Adult-use: any visitor 21 or older with a government-issued photo ID may purchase from a licensed adult-use retailer under the 1 oz / 5 g cap.
• Medical: Rhode Island honors out-of-state medical cards at licensed compassion centers (medical dispensaries). The visiting patient presents the out-of-state card plus a government photo ID.

The medical-program access pathway provides the visiting patient with medical-specific products and pricing not available at adult-use retail. The state's small geographic footprint makes reciprocity particularly relevant for Connecticut and Massachusetts medical patients.

Plant-tag cultivation framework

Rhode Island uses a unique plant-tag system for both medical patient cultivation and licensed cultivator operations. Patients with cultivation authorization receive a finite number of plant tags from the Office of Cannabis Regulation. Each plant in the patient's grow must carry an active tag traceable to the registered patient or caregiver. Tags expire and must be renewed.

The plant-tag system was designed to prevent diversion and provide a chain-of-custody framework. For medical patients, tags allow up to 12 mature plants and 12 seedlings, substantially above the household adult-use cap of 6 mature.

Employment and workplace

Rhode Island provides moderate employment protections for medical patients under R.I.G.L. §21-28.6-4. The Cannabis Act layered limited adult-use considerations, but employers retain broad authority:

• Medical patient discrimination: employers may not take adverse action against an employee solely on the basis of medical patient status.
• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles as defined by the employer.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• Adult-use: no statutory off-duty use protection for adult-use cannabis as of mid-2026.
• Workers' compensation: post-incident testing positive for THC may affect benefits if impairment is established.

Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Hemp-derived intoxicants

Rhode Island placed hemp-derived intoxicating cannabinoids under the Cannabis Control Commission's regulatory authority through Cannabis Act amendments. Delta-8 THC, delta-9 THC from hemp, delta-10 THC, THC-O, HHC, and similar compounds are restricted to retail channels licensed under the cannabis framework. Hemp-derived products with total THC above defined thresholds are not lawful for retail sale outside the licensed cannabis supply chain.

Recent legislative and regulatory history

Notable developments:

• 2006: Slater Medical Marijuana Act enacted over Governor's veto.
• 2009-2013: compassion center licensing framework established.
• 2022: Rhode Island Cannabis Act enacted May 25; Cannabis Control Commission established.
• 2022: licensed adult-use retail sales began December 1 (the fastest medical-to-adult-use launch nationally).
• 2023-2024: social-equity license categories rolled out; on-premises consumption framework adopted.
• 2025-2026: continued legislative work on hemp-derived intoxicant rules, social-equity license expansion, and dispensary licensing balance.

The April 2026 federal Schedule III rescheduling order produced no immediate Rhode Island legislative response.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Naval Station Newport, Naval Undersea Warfare Center), and interstate highways. Rhode Island Sound and Block Island Sound federal-waters jurisdiction also applies to boating cannabis-possession scenarios. Roger Williams National Memorial and other National Park Service properties fall under federal cannabis prohibition regardless of state authorization. I-95, I-195, and I-295 corridors see federal drug-interdiction activity, particularly at the Connecticut and Massachusetts borders (both adult-use legal, reducing cross-state purchase pressure).